No Detail Found!

Antibody Responses Following Covid-19 Vaccine in Pregnant Women- A Prospective Study

Author(s)
Zunaira Hamayun Department of Physiology, Multan Medical and Dental College Multan, Pakistan
Usman Javaid Department of Health Care, Services Institute of Health Sciences (SIMS), Lahore, Pakistan
Rizwan Ahmed Department of Biochemistry, Independent Medical College, Faisalabad, Pakistan
Khurram Shehzad Department of Physiology, Independent Medical College, Faisalabad, Pakistan
Pari Imam Gul Department of Gynae and Obse, Mukhtar A Sheikh Memorial Welfare Hospital, Multan, Pakistan
Abstract
Objective: To assess the antibody responses and adverse effects of sinopharm vaccine in pregnant women. Study Design: A prospective cohort study. Place and Duration of Study: The study was conducted in the Gynaecology Department of Ibn-e-Siena Hospital Multan, Independent Hospital Faisalabad and Mayo Hospital Lahore from January 2021 to January 2022. Materials and Methods: A total of 90 women were included in the study who were administered Sinopharm. Three out of ninety (3.3%) women received shots in 1st trimester, 56/90 (62%) in 2nd trimester and 31/90 (34%) in third trimester. Enzyme-linked immunosorbent assay (ELISA) was used to measure SARS-CoV-2 receptor binding domain (RBD) specific total antibodies and angiotensin-converting enzyme 2 (ACE2) blocking antibodies. The adverse effects on the mother and fetus were evaluated after the delivery. Results: The administration of the sinopharm vaccine showed no adverse effects or pregnancy complications such as congenital anomalies, miscarriage, preterm delivery, thrombotic events, fetal death or hypertensive disorders. SARS-CoV-2 specific total antibodies were found in 57/90 (63%) women at the time recruitment (when receiving 1st dose); thus they were considered to be previously infected. After the second dose, all women were seroconverted. Significantly high levels of RBD binding antibodies and ACE2 blocking antibodies were observed in previously infected women after administration of the second dose compared to uninfected individuals. Conclusion: The Sinopharm vaccine showed positive results in pregnant women and induced high seroconversion rates and ACE2 blocking antibodies in second and third trimesters.
Publication Details
Page(s) 196-199
DOI DOI not available
Published Journal: Life and Science, Volume: 3, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
ACE2 Blocking Antibodies, Receptor Binding Antibodies, Pregnant Women SARS-CoV-2
0

Citations

0

Downloads

51

Views